Novo Will Slash US List Prices for Wegovy, Ozempic Next Year
Original Report
Novo Nordisk A/S plans to slash the US list prices for its blockbusters Wegovy and Ozempic next year as the drugmaker struggles to claw back a larger share of the obesity market.
Glass House Analysis
Inflation is the silent tax that erodes purchasing power, hitting hardest those who can least afford it. When grocery bills rise faster than wages, families face impossible choices between food, medicine, and rent. Unlike market volatility that mainly affects investors, inflation touches everyone who buys groceries, fills a gas tank, or pays rent.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Meta strikes AI chip deal with AMD days after committing to deploy millions of Nvidia GPUs
AMD has secured Meta as a customer for its Helios rack-scale system, as Nvidia's Blackwell faces heightened competition.
I paid $20,000 to learn hard lessons about trading options
Read this before putting your money on options trades. Plus: Money tips from readers like you.
Panama cancels China-linked port deal, hands canal terminals to Maersk, MSC
The simmering dispute has become a geopolitical flashpoint between Washington and Beijing, with Panama caught in the crossfire.
Google to build data center in Minnesota with new solar, wind power and battery storage
"What Google is doing is ensuring that when we show up, we aren't putting additional costs on other ratepayers," its head of data center energy told CNBC.